Jin Ye-ning

Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial

Yuankai Shi, Li Zhang, Xiaoqing Liu et al. · The Lancet Oncology · 2013 · 420 citations

Double-blind Phase 3, Medicine, Metronomic Therapy +9

Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells

Weiguo Cao, Rong Fan, Lifu Wang et al. · Tumor Biology · 2012 · 81 citations

Using detection of survivin‐expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer

Weiguo Cao, Weiping Yang, Hao Li et al. · Journal of Surgical Oncology · 2010 · 43 citations

Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer

Weiguo Cao, Yang Weiping, Guying Lou et al. · Anti-Cancer Drugs · 2009 · 22 citations

Advanced Gastric Cancer, Cancer Management, Gastroenterology +17

Intraurethral Brachytherapy for Prevention of Recurrent Urethral Stricture After Internal Urethrotomy or Transurethral Resection of Scar

Yinghao Sun, Chuanliang Xu, Xu Gao et al. · Journal of Endourology · 2001 · 21 citations